Xue, Kai
Wu, Ji-Chuan
Li, Xi-Ya
Li, Ran
Zhang, Qun-ling
Chang, Jin-Jia
Liu, Yi-Zhen
Xu, Chun-Hui http://orcid.org/0000-0002-3836-3179
Zhang, Jia-Ying
Sun, Xiao-Jian http://orcid.org/0000-0001-8826-4614
Gu, Juan J.
Guo, Wei-Jian http://orcid.org/0000-0002-6155-8345
Wang, Lan http://orcid.org/0000-0003-3545-5059
Article History
Received: 21 April 2021
Revised: 10 August 2021
Accepted: 15 September 2021
First Online: 1 October 2021
Competing interests
: The authors declare no competing interests.
: Primary relapsed patient cells were obtained from puncture samples from consenting patients with rituximab or chemotherapy treatment failure. Informed consent was obtained from all subjects for the collection and use of samples. All animal interventions were approved by the ethics committee. Approval number of committees for ethical review is SINH-2021-WL-3.